Organon & Co | OGN - القيمة السوقية





القيمة السوقية تغيير تاريخ
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Cspc Pharmaceutical CNY 99.86B 3.93B 2026-08
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 4.58B 2.8B 2026-03
Divis Laboratories Ltd INR 2.21T 464.84B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
Glaxosmithkline GBP 109.29B 9.36B 2026-03
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 133.52M 29.05M 2026-08
Medical Developments International AUD 37.11M 25.41M 2026-08
Merck USD 324.18B 6.81B 2026-08
Neuren Pharmaceuticals AUD 2.44B 80.57M 2026-08
Novartis USD 288.26B 25.18B 2026-03
Organigram Holdings CAD 252.47M 59.69M 2026-03
Organon & Co USD 3.51B 52.64M 2026-08
Ovoca Bio EUR 5.1M 3.93M 2026-08
Pharma Mar EUR 1.39B 78.26M 2026-08
Qiagen NV USD 8.47B 396.81M 2026-08
Sartorius EUR 15.63B 1.38B 2026-06
Zealand Pharma A/S 33.35B 12.51B 2026-08